Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:21:43 EDT Sat 12 Jul 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.12.90·2.981.02.93-0.13-4.236.41011213.06  3.12  2.895.56  1.7115:59:00Jun 2515 min RT 2¢
TSX - T0.12.90·2.981.02.93-0.13-4.224.067703.06  3.12  2.895.56  1.7115:59:0015 min
NEO ATS - U 2.95-0.11-3.60.1012.95  2.95  2.9513:26:3815 min
Alpha - A 2.99-0.07-2.33.3953.12  3.12  2.9410:53:5015 min
Pure - P 2.92-0.14-4.63.1983.12  3.12  2.9014:54:0415 min
Chi-X - X 2.99-0.07-2.30.2112.99  2.99  2.9910:48:2215 min
CX2 - H 2.90-0.16-5.23.61083.02  3.02  2.9014:54:0315 min
CXD - D 2.91-0.15-4.90.30142.91  2.91  2.9114:54:0315 min
TriAct - M 3.060.829    Sep 11/2015 min
Lynx - Y 2.93-0.13-4.20.9232.99  2.99  2.8915:59:0015 min
CS2 - S 3.060.032    Mar 2015 min

Recent Trades - Last 10 of 121
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:00Y2.93-0.1310080 National Bank79 CIBCK
15:59:00T2.93-0.1310080 National Bank14 Virtu ITGK
15:59:00T2.93-0.1330080 National Bank7 TD SecK
15:56:57D2.93-0.136124 Questrade80 National BankE
15:54:53D2.93-0.131124 Questrade2 RBCE
15:53:49D2.93-0.136124 Questrade7 TD SecE
15:52:11D2.93-0.1312124 Questrade80 National BankE
15:50:48D2.93-0.1312124 Questrade2 RBCE
14:54:04P2.92-0.145001 Anonymous80 National BankK
14:54:04Y2.89-0.1730079 CIBC19 DesjardinsK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-25 18:40C:MDP3.35SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 18:40C:MDP3.35SEDAR MD & ASEDAR MD & A
2025-06-25 18:29C:MDP3.35SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 18:16C:MDP3.35News ReleaseMedexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States
2025-06-17 20:20C:MDP3.03News ReleaseMedexus to file fiscal 2025 results June 25
2025-04-17 16:34C:MDP2.55News ReleaseMedexus completes listing agreement for Trecondyv
2025-04-07 16:19C:MDP2.17News ReleaseMedexus talks up market response to Grafapex
2025-03-14 14:15C:MDP2.57News ReleaseMedexus completes cancellation of Gleolan U.S. licence
2025-02-24 16:32C:MDP2.98News ReleaseMedexus's Grafapex for injection available in U.S.
2025-02-07 05:42C:MDP3.21In the NewsGlobe says Medexus Pharmaceuticals lowered to "hold"
2025-02-06 10:51C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-02-06 10:45C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDP
2025-02-06 10:35C:MDP3.79Resume TradingMedexus Pharmaceuticals to resume at 7:36 a.m. PT
2025-02-06 10:34C:MDP3.79Halt TradingMedexus Pharmaceuticals halted at 7:31 a.m. PT
2025-02-05 17:39C:MDP3.79SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-05 17:38C:MDP3.79SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-02-05 17:31C:MDP3.79News ReleaseMedexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States
2025-02-04 17:54C:MDP3.87News ReleaseMedexus completes listing agreements with Ontario
2025-01-31 18:21C:MDP3.85News ReleaseMedexus to release fiscal Q3 results Feb. 5
2025-01-31 16:44C:MDP3.85News ReleaseMedexus Pharmaceuticals closes $30-million offering